면역결핍 모델에서 β-1,3/1,6-glucan과 유산균을 이용한 in vivo 면역 활성 조절 효과
Immunomodulatory effects of β-1,3/1,6-glucan and lactic acid bacteria in LP-BM5 murine leukemia viruses-induced murine acquired immune deficiency syndrome
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
In this study, β-1,3/1,6-glucan, lactic acid bacteria, and β-1,3/1,6-glucan+lactic acid bacteria were tested for 10 weeks using an immunodeficient animal model infected with LP-BM5 murine AIDS virus On the immune activity. Cytokines production, plasma immunoglobulin concentration, T cell and B cell proliferation were measured. As a result, the T cell proliferative capacity which was weakened by immunization with LP-BM5 murine AIDS virus increased significantly T cell proliferative capacity compared with the red ginseng control group. B cell proliferative capacity was significantly higher than the infected control group. Increased B cell proliferation was reduced. In the cytokine production, IL-2, IL-12 and IL-15 in the Th1-type cytokine increased the secretion of IL-2, IL-12 and IL-15 compared to the infected control. The proliferative capacity of the treated group was higher than that of the mixed treatment group. TNF-α was significantly decreased compared with the infected control group. The IL-4, IL-6 and IL-10 levels were significantly inhibited in the infected control group and the Th1/Th2 type cytokine expression was regulated by immunohistochemistry. IgE, IgA, and IgG levels were significantly lower in the immunoglobulin secretion assay than in the control. As a result, the immunomodulatory effect of β-1,3/1,6-glucan+lactic acid bacteria was confirmed by mixing with LP-BM5 murine AIDS virus-infected immunodeficient animal model.
Abstract
In this study, β-1,3/1,6-glucan, lactic acid bacteria, and β-1,3/1,6-glucan+lactic acid bacteria were tested for 10 weeks using an immunodeficient animal model infected with LP-BM5 murine AIDS virus On the immune activity. Cytokines production, plasma immunoglobulin concentration, T cell and B cell proliferation were measured. As a result, the T cell proliferative capacity which was weakened by immunization with LP-BM5 murine AIDS virus increased significantly T cell proliferative capacity compared with the red ginseng control group. B cell proliferative capacity was significantly higher than the infected control group. Increased B cell proliferation was reduced. In the cytokine production, IL-2, IL-12 and IL-15 in the Th1-type cytokine increased the secretion of IL-2, IL-12 and IL-15 compared to the infected control. The proliferative capacity of the treated group was higher than that of the mixed treatment group. TNF-α was significantly decreased compared with the infected control group. The IL-4, IL-6 and IL-10 levels were significantly inhibited in the infected control group and the Th1/Th2 type cytokine expression was regulated by immunohistochemistry. IgE, IgA, and IgG levels were significantly lower in the immunoglobulin secretion assay than in the control. As a result, the immunomodulatory effect of β-1,3/1,6-glucan+lactic acid bacteria was confirmed by mixing with LP-BM5 murine AIDS virus-infected immunodeficient animal model.
참고문헌 (30)
- Tomasi TB Jr, "Characteristics of an immune system common to certain external secretions", J Exp Med, 121, pp.101~124 (1965)
- Gonzalez-Rey E, "Regulation of immune tolerance by anti-inflammatory neuropeptides", Nat Rev Immunol, 7, pp.52~63 (2007)
- Kim JS, "Mechanism of aging and prevention", Immune Network, 1, pp.104~108 (2001)
- Health functional food market trends and consumer survey, "KHSA", Korea Health Supplements Association, 142~144 (2016)
- McIntosh M, "Curdlan and other bacterial(1→ 3)-β-D-glucans", Appl Microbiol Biotechnol, 68, pp.163~173 (2005)
- Cui SW, "Cell wall polysaccharides in cereals : chemical structures and functional properties", Struct Chem, 20, pp.291~297 (2009)
- Matse AM, "Effects of high isostatic pressure on mushrooms", J Food Eng, 45, pp.11~16 (2000)
- Kimura Y, "Antitumor and antimetastatic activity of a novel water-soluble low molecular weight β-1, 3-D-glucan(branch β-1, 6)isolated from Aureobasidium pullulans 1A1 strain black yeast", Anticancer Res, 26, pp.4131~4141 (2006)
- Brown GD, "Immune recognition of fungal β glucans", Cell Microbiol, 7, pp.471~479 (2005)
- Brown GD, "Dectin-1 : a signalling non-TLR pattern-recognition receptor", Nat Rev Immunol, 6, pp.33~43 (2006)
- Lee DH, "Innate immunity induced by fungal β-glucans via dectin-1 signaling pathway", Int J Med Mushrooms, 16, pp.1~16 (2014)
- Brown GD, "Dectin-1 is a major β-glucan receptor on macrophages", J Exp Med, 196, pp.407~412 (2002)
- Furrie E, "Probiotics and allergy", Proc Nutr Soc, 64, pp.465~469 (2005)
- Park HS, "Selection of microorganisms for probiotics and their characterization", J Korean Soc Food Sci Nutr, 27, pp.433~440 (1998)
- Rather IA, "Probiotics and Atopic Dermatitis: An Overview", Front Microbiol, 7, pp.1~7 (2016)
- Laiho K, "Probiotics: on-going research on atopic individuals", Br J Nutr, 88, pp.S19~S27 (2002)
- Kim HJ, "Effects of Lactobacillus rhamnosus on allergic march model by suppressing Th2, Th17, and TSLP responses via CD4(+)CD25(+)Foxp3(+)Tregs", Clin immunol, 153, pp.178~186 (2014)
- 윤종영, "Aureobasidium pullulans으로 부터 분리한 β-1,3", 1,6-glucan의 면역활성의 연구, 2016, pp.23(6), 906~912[DOI]
- 이석준, "Aureobasidium pullulans IMS-822가 생산하는 β-(1→3)(1→6)-Glucan의 특성 분석", 미생물학회지, 45(1), pp.63~68 (2009), 한국미생물학회
- W Oboshi, "Effects of β-glucan and lactic acid bacteria on gut immune system", Jap J Med Technol, 63, pp.673~679 (2014)
- Iida R, "Suppression of neurocognitive damage in LP-BM5-infected mice with a targeted deletion of the TNF-α gene", FASEB J, 14, pp.1023~1031 (2000)
- Liang B, "Murine AIDS, a key to understanding retrovirus-induced immunodeficiency", Viral Immunol, 9, pp.225~239 (1996)
- Odeleye OE, "Changes in hepatic lipid composition after infection by LP-BM5 murine leukemia virus causing murine AIDS", Life Sci, 51, pp.129~134 (1992)
- Dimitrov DS, "A mechanism of resistance to HIV-1 entry : inefficient interactions of CXCR4 with CD4 and gp120 in macrophages", Virology, 259, pp.1~6 (1999)
- Moir S, "B cells in early and chronic HIV infection : evidence for preservation of immune function associated with early initiation of antiretroviral therapy", Blood, 116, pp.5571~5579 (2010)
- Gougeon ML, "Programmed cell death in peripheral lymphocytes from HIV-infected persons : increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression", J Immunol, 156, pp.3509~3520 (1996)
- Morris L, "HIV-1 antigen-specific and-nonspecific B cell responses are sensitive to combination antiretroviral therapy", J Exp Med, 188, pp.233~245 (1998)
- Meyaard L, "T-cell dysfunction in HIV infection: anergy due to defective antigen- presenting cell function?", Immunol Today, 14, pp.161~164 (1993)
- Zimmerli SC, "HIV-1-specific IFN-γ", IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells, 2005, pp.102, 7239~7244
- Moir S, "B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells", J Exp Med, 192, pp.637~645 (2000)